Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 50 and 90 years, whether currently in hospital or attending as outpatients.
- People who have been diagnosed with early-stage Alzheimer's-related memory problems (either mild cognitive impairment or mild dementia) based on recognised 2018 diagnostic guidelines.
- People whose memory and thinking test scores fall within a specific range — a score of 18–26 on the MMSE test and a score of 0.5 or 1 on the CDR scale.
- People whose test results show signs of Alzheimer's disease in the brain, either through a special brain scan (amyloid PET), a spinal fluid test, or a blood test measuring a specific protein (phosphorylated Tau217).
- People who are able to communicate in Chinese and are not illiterate.
- People who are currently taking certain memory medications (such as donepezil or rivastigmine) at a stable, unchanged dose for at least 6 weeks in a row, with no planned dose changes during the study.
- People who have signed a form giving their consent to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose memory or thinking problems came on suddenly.
- People who have early signs of localised brain or movement-related neurological symptoms.
- People who have other health conditions that may affect memory or thinking, such as liver or kidney problems, hormonal disorders, vitamin deficiencies, brain injury, epilepsy, brain infections, or a condition called normal pressure hydrocephalus.
- People who meet the medical diagnostic criteria for depression or schizophrenia (confirm with trial site).
- People who are currently taking medications that may interfere with the study's test results.
- People who cannot safely have an MRI scan due to metal implants or electronic devices in their body, such as a pacemaker, defibrillator, implanted electronic system, vascular clip, mechanical heart valve, or cochlear implant.
- People whose brain MRI scan shows a pattern of reduced blood flow to the brain that meets specific medical criteria (NINCDS-AIREN criteria) (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yi Tang, M.D., Ph.D., Xuanwu Hospital, Beijing
Phone: 00861083199456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-cog, 13-items version).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.